{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:27:21Z","timestamp":1785583641684,"version":"3.56.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,29]]},"DOI":"10.7759\/cureus.85015","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T10:10:42Z","timestamp":1748513442000},"source":"Crossref","is-referenced-by-count":2,"title":["Splenic Diffuse Red Pulp Small B-cell Lymphoma: A Rare Diagnosis in a Patient With Incidental Abnormal Lymphocytosis"],"prefix":"10.7759","author":[{"given":"Aarish","family":"Lalani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshniben","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Mohiuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxman","family":"Wagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow SH","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al.. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016, 127:2375-90. 10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms","volume":"36","author":"Alaggio R","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms. Leukemia. 2022, 36:1720-48. 10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2014-0291-CC","article-title":"Diagnosis of splenic B-cell lymphomas in the bone marrow: a review of histopathologic, immunophenotypic, and genetic findings","volume":"138","author":"Behdad A","year":"2014","unstructured":"Behdad A, Bailey NG. Diagnosis of splenic B-cell lymphomas in the bone marrow: a review of histopathologic, immunophenotypic, and genetic findings. Arch Pathol Lab Med. 2014, 138:1295-301. 10.5858\/arpa.2014-0291-CC","journal-title":"Arch Pathol Lab Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol28060431","article-title":"A review on splenic diffuse red pulp small B-cell lymphoma","volume":"28","author":"Yilmaz E","year":"2021","unstructured":"Yilmaz E, Chhina A, Nava VE, Aggarwal A. A review on splenic diffuse red pulp small B-cell lymphoma. Curr Oncol. 2021, 28:5148-54. 10.3390\/curroncol28060431","journal-title":"Curr Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-168197","article-title":"Splenic diffuse red pulp small B-cell lymphoma descriptors and clinicopathologic determinants of clinical outcomes: analysis of a pooled database","volume":"140","author":"Gupta S","year":"2022","unstructured":"Gupta S, Graham C, Haddad PA. Splenic diffuse red pulp small B-cell lymphoma descriptors and clinicopathologic determinants of clinical outcomes: analysis of a pooled database. Blood. 2022, 140:3632. 10.1182\/blood-2022-168197","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2016.03.011","article-title":"A single-center experience in splenic diffuse red pulp lymphoma diagnosis","volume":"16 Suppl","author":"Julhakyan HL","year":"2016","unstructured":"Julhakyan HL, Al-Radi LS, Moiseeva TN, et al.. A single-center experience in splenic diffuse red pulp lymphoma diagnosis. Clin Lymphoma Myeloma Leuk. 2016, 16 Suppl:S166-9. 10.1016\/j.clml.2016.03.011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.013714","article-title":"Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features","volume":"95","author":"Kanellis G","year":"2010","unstructured":"Kanellis G, Mollejo M, Montes-Moreno S, et al.. Splenic diffuse red pulp small B-cell lymphoma: revision of a series of cases reveals characteristic clinico-pathological features. Haematologica. 2010, 95:1122-9. 10.3324\/haematol.2009.013714","journal-title":"Haematologica"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-098848","article-title":"Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?","volume":"111","author":"Traverse-Glehen A","year":"2008","unstructured":"Traverse-Glehen A, Baseggio L, Bauchu EC, et al.. Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?. Blood. 2008, 111:2253-60. 10.1182\/blood-2007-07-098848","journal-title":"Blood"},{"key":"ref9","article-title":"Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity","volume":"13","author":"Traverse-Glehen A","year":"2012","unstructured":"Traverse-Glehen A, Baseggio L, Salles G, Coiffier B, Felman P, Berger F. Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity. Discov Med. 2012, 13:253-65.","journal-title":"Discov Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12288-022-01621-2","article-title":"Splenic lymphomas: a tertiary care center experience and review of literature","volume":"39","author":"Jain S","year":"2023","unstructured":"Jain S, Ramteke P, Gogia A, et al.. Splenic lymphomas: a tertiary care center experience and review of literature. Indian J Hematol Blood Transfus. 2023, 39:402-12. 10.1007\/s12288-022-01621-2","journal-title":"Indian J Hematol Blood Transfus"},{"key":"ref11","article-title":"A rare case of splenic diffuse red pulp small B-cell lymphoma: one case report and relevant literature review","volume":"4","author":"Wang Y","year":"2019","unstructured":"Wang Y, Dai J, Zou M, Jiang C, Li H, Wang X, Xiao R. A rare case of splenic diffuse red pulp small B-cell lymphoma: one case report and relevant literature review. Clin Oncol. 2019, 4:1592.","journal-title":"Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55374","article-title":"Splenic marginal zone lymphoma in a patient with antiphospholipid syndrome treated with rituximab: a case report","volume":"16","author":"Wagle L","year":"2024","unstructured":"Wagle L, Regmi DR, Adhikari S, Basnyat P, Kalla A. Splenic marginal zone lymphoma in a patient with antiphospholipid syndrome treated with rituximab: a case report. Cureus. 2024, 16:e55374. 10.7759\/cureus.55374","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2211582","article-title":"Zanubrutinib or ibrutinib in relapsed or refractory chronic lymphocytic leukemia","volume":"388","author":"Brown JR","year":"2023","unstructured":"Brown JR, Eichhorst B, Hillmen P, et al.. Zanubrutinib or ibrutinib in relapsed or refractory chronic lymphocytic leukemia. N Engl J Med. 2023, 388:319-32. 10.1056\/NEJMoa2211582","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006844","article-title":"A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenstr\u00f6m macroglobulinemia: the ASPEN study","volume":"136","author":"Tam CS","year":"2020","unstructured":"Tam CS, Opat S, D'Sa S, et al.. A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenstr\u00f6m macroglobulinemia: the ASPEN study. Blood. 2020, 136:2038-50. 10.1182\/blood.2020006844","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/336292-splenic-diffuse-red-pulp-small-b-cell-lymphoma-a-rare-diagnosis-in-a-patient-with-incidental-abnormal-lymphocytosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T10:10:43Z","timestamp":1748513443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/336292-splenic-diffuse-red-pulp-small-b-cell-lymphoma-a-rare-diagnosis-in-a-patient-with-incidental-abnormal-lymphocytosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.85015","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,29]]}}}